NCT06931301View on ClinicalTrials.gov

Effect of HBOT on Femoral Head Avascular Necrosis (AVN)

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

April 30, 2035

Study Completion Date

April 30, 2035

Conditions
OsteonecrosisAvascular Necrosis
Interventions
DEVICE

Hyperbaric Oxygen Therapy

Sechrist Monoplace Hyperbaric Chamber Model 3600, Chamber will be used to supply patients with 100% oxygen to breathe at 2-2.4 ATA (the equivalent of diving to 33 - 45 feet of sea water) for two hours, 5 treatments per week

Trial Locations (1)

06520

Yale New Haven Health System, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT06931301 - Effect of HBOT on Femoral Head Avascular Necrosis (AVN) | Biotech Hunter | Biotech Hunter